Skip to main content

scPharmaceuticals Inc.

SCPHDelisted Oct 7, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001604950

scPharmaceuticals Inc. was delisted on Oct 7, 2025; its insiders filed their last Form 4 on Oct 7, 2025; 110 institutions reported holding it in 13F filings for Q3 2025, worth $232.3M in total; no superinvestor held it.

Q2 2021 vs. Q1 2021

How the institutions holding scPharmaceuticals Inc. changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of SCPH: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders4638−8
Shares17.2M16.0M−1.12M (−6.6%)
Value$114.1M$97.9M−$16.1M (−14.1%)

New holders (5)

Institutions that held scPharmaceuticals Inc. at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to SCPH in Q2 2021
InstitutionSharesValue% of portfolio
Russell Investments Group, Ltd.194,238$1.19M0.00%
Millennium Management LLC57,717$353.0K0.00%
Zacks Investment Management36,989$226.0K0.00%
Ergoteles LLC27,872$170.0K0.00%
HRT Financial LP20,261$123.0K0.00%

Sold out (13)

Institutions that held scPharmaceuticals Inc. at the end of Q1 2021 and filed for Q2 2021 without it.

Institutions that sold out of SCPH in Q2 2021
InstitutionShares, Q1 2021Value, Q1 2021
Alyeska Investment Group, L.P.355,690$2.37M
State Street Corp104,119$692.0K
Nuveen Asset Management, LLC32,739$218.0K
Charles Schwab Investment Management Inc14,397$96.0K
Invesco Ltd.10,726$71.0K
California State Teachers Retirement System10,596$70.0K
Deutsche Bank AG4,495$30.0K
American International Group, Inc.4,079$27.0K
Legal & General Group Plc827$6.00K
Citigroup Inc465$3.00K
Panagora Asset Management Inc470$3.00K
Ameritas Investment Partners, Inc.475$3.00K
Bank of Montreal261$2.00K